Summary of Significant Accounting Policies (Details 3) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013 item	Mar. 31, 2012
Summary of Significant Accounting Policies
Number of business segments			1
Number of reportable segments			1
Medical Indication Information
Total	$ 39,022	$ 30,688	$ 110,880	$ 87,300
Antibiotic
Medical Indication Information
Total	3,496	1,662	6,267	4,798
Cardiovascular
Medical Indication Information
Total	6,988	6,050	21,356	11,512
Gallstone
Medical Indication Information
Total	1,390	1,419	4,676	4,286
Glaucoma
Medical Indication Information
Total	1,627	993	4,608	3,093
Gout
Medical Indication Information
Total	1,776	110	2,907	482
Migraine Headache
Medical Indication Information
Total	1,299	1,442	3,995	4,601
Obesity
Medical Indication Information
Total	1,074	979	3,488	2,570
Pain Management
Medical Indication Information
Total	4,980	4,043	14,752	14,609
Thyroid Deficiency
Medical Indication Information
Total	14,024	12,543	42,135	36,788
Other
Medical Indication Information
Total	$ 2,368	$ 1,447	$ 6,696	$ 4,561